These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3379102)

  • 1. Modulation of the epidermal growth factor receptor by brain-derived growth factor in Swiss mouse 3T3 cells.
    Huang SS; Lokeshwar VB; Huang JS
    J Cell Biochem; 1988 Mar; 36(3):209-21. PubMed ID: 3379102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ; Houtman JC; Cha D; Bertics PJ
    J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid.
    Winston JT; Olashaw NE; Pledger WJ
    J Cell Biochem; 1991 Sep; 47(1):79-89. PubMed ID: 1658015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the epidermal growth factor receptor by mitogenic ligands: effects of bombesin and role of protein kinase C.
    Zachary I; Rozengurt E
    Cancer Surv; 1985; 4(4):729-65. PubMed ID: 3916643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.
    Bird TA; Saklatvala J
    J Immunol; 1989 Jan; 142(1):126-33. PubMed ID: 2783320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor.
    Jetten AM
    J Cell Physiol; 1982 Mar; 110(3):235-40. PubMed ID: 6282898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter.
    Wattenberg EV; Fujiki H; Rosner MR
    Cancer Res; 1987 Sep; 47(17):4618-22. PubMed ID: 2887282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of EGF-receptors by phorbol ester in small intestinal crypt cells.
    Baliga BS; Borowitz SM; Barnard JA
    Biochem Int; 1990; 20(1):161-8. PubMed ID: 2328019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous regulation of EGF receptors in fibroblastic cells.
    Olashaw NE; Pledger WJ
    J Cell Biochem; 1987 Jun; 34(2):143-9. PubMed ID: 3496345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
    J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of phorbol esters on cell growth and epidermal growth factor receptor modulation in a human gastric carcinoma cell line TMK-1.
    Ochiai A; Yasui W; Kameda T; Takanashi A; Takekura N; Tahara E
    Hiroshima J Med Sci; 1989 Dec; 38(4):191-5. PubMed ID: 2637248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
    Pietenpol JA; Howe PH; Cunningham MR; Leof EB
    J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous and heterologous mitogenic desensitization of Swiss 3T3 cells to phorbol esters and vasopressin: role of receptor and postreceptor steps.
    Collins MK; Rozengurt E
    J Cell Physiol; 1984 Feb; 118(2):133-42. PubMed ID: 6319436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of type alpha transforming growth factor receptors by a phorbol ester tumor promoter.
    Davis R; Like B; Massagué J
    J Cell Biochem; 1985; 27(1):23-30. PubMed ID: 2984222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the epidermal growth factor receptor by basic fibroblast growth factor.
    Maher PA
    J Cell Physiol; 1993 Feb; 154(2):350-8. PubMed ID: 8425916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.